Selecta Biosciences Inc (SELB): OrbiMed Advisors Reports New Stake

Page 12 of 13

Page 12 of 13 – SEC Filing
Schedule II
 
The business and operations of OrbiMed Capital GP III LLC are managed by the executive officers and directors of its managing member, OrbiMed Advisors LLC, set forth on Schedule I.

Follow Cartesian Therapeutics Inc.

Page 12 of 13